COVID-19 Survivors Have Broad, Longer-Term Immunity
Coronavirus,Coronavirus Vaccine,Vaccine Mandates,Herd Immunity,Delta Variant
People who have recovered from COVID-19 retain broad and effective longer-term immunity to the disease, according to a new study.
Findings of the study, which is the most comprehensive of its kind so far, have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
For the longitudinal study in Cell Reports Medicine, researchers looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period of more than eight months (250 days) and found that their immune response to the virus remained durable and strong.
The findings are reassuring, especially given early reports during the pandemic that protective neutralizing antibodies didn’t last in COVID-19 patients, said Rafi Ahmed, director of the Emory University Vaccine Center and a lead author of the paper.
“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection. We also saw indications in this phase that natural immunity could continue to persist,” Ahmed said.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Is Anthropic Losing Its Identity as an AI Safety Leader?
November 20th, 2026
Headline Roundup
Trump Replaces National Cyber Director Amid Questions Over Recent Technology Outages
November 20th, 2026
Recommended Reading
Do Phones Belong in Class?: Understanding the Phone-Free Schools Debate
The Alliance for Civic Engagement
November 20th, 2026